These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 6335396

  • 1. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 2. The modulation of immune complex aggregation by classical pathway-mediated reactions.
    Gronski P, Bodenbender L, Kanzy EJ, Loos M, Seiler FR.
    Immunobiology; 1985 May; 169(4):346-61. PubMed ID: 3874147
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 4. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 5. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
    Daha MR, Hazevoet HM, Vanes LA.
    Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
    [Abstract] [Full Text] [Related]

  • 6. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC, Kovacsovics TJ, Tschopp J, Isliker H.
    J Immunol; 1987 Mar 15; 138(6):1871-6. PubMed ID: 3029223
    [Abstract] [Full Text] [Related]

  • 7. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
    Gronski P, Bodenbender L, Kanzy EJ, Piepenbrock M, Seiler FR.
    Immunobiology; 1986 Apr 15; 171(3):252-62. PubMed ID: 3011651
    [Abstract] [Full Text] [Related]

  • 8. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 9. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E, Schumaker VN, Phillips ML, Curtiss LK.
    J Immunol; 1986 Jul 01; 137(1):255-62. PubMed ID: 3486914
    [Abstract] [Full Text] [Related]

  • 10. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G, van Es LA, Daha MR.
    Immunology; 1983 Jun 01; 49(2):215-22. PubMed ID: 6852866
    [Abstract] [Full Text] [Related]

  • 11. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK, Hamilton AO, Yeung-Laiwah AC, Whaley K.
    Clin Exp Immunol; 1984 Nov 01; 58(2):486-92. PubMed ID: 6333948
    [Abstract] [Full Text] [Related]

  • 12. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB, Sjöholm AG.
    Behring Inst Mitt; 1993 Dec 01; (93):292-8. PubMed ID: 8172579
    [Abstract] [Full Text] [Related]

  • 13. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
    Schifferli JA, Woo P, Peters DK.
    Clin Exp Immunol; 1982 Mar 01; 47(3):555-62. PubMed ID: 6979442
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F, Kijlstra A.
    Immunology; 1985 Mar 01; 54(3):449-56. PubMed ID: 3844370
    [Abstract] [Full Text] [Related]

  • 15. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ, Peitsch MC, Kress A, Isliker H.
    J Immunol; 1987 Mar 15; 138(6):1864-70. PubMed ID: 3029222
    [Abstract] [Full Text] [Related]

  • 16. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT, Cooper NR, Schreiber RD.
    J Immunol; 1979 Jan 15; 122(1):34-8. PubMed ID: 762421
    [Abstract] [Full Text] [Related]

  • 17. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC.
    J Immunol; 1982 Jul 15; 129(1):168-72. PubMed ID: 6979566
    [Abstract] [Full Text] [Related]

  • 18. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK, Holme E, Hamilton E, Whaley K.
    Clin Exp Immunol; 1985 Apr 15; 60(1):169-77. PubMed ID: 3159522
    [Abstract] [Full Text] [Related]

  • 19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 15; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 20. Control of immune complexes by the classical pathway.
    Whaley K, Ahmed AE.
    Behring Inst Mitt; 1989 Jul 15; (84):111-20. PubMed ID: 2529842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.